A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
Clinical trial NCT04991753 · COMPLETED
Trial details
- NCT number
- NCT04991753
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-14
- Primary completion
- 2022-08-10
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.